|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net revenue | |||||
| Product | |||||
| Royalty and other | |||||
| Total net revenue | |||||
| Product | |||||
| Royalty and other | |||||
| Total net revenue | |||||
| Cost of net revenue | |||||
| Gross profit | |||||
| Operating expenses | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Severance and software license obligations | |||||
| Gain on license and asset sale | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest expense | |||||
| Change in fair value of warrant liabilities | |||||
| Other income, net | |||||
| Other income (expense), net | |||||
| Net loss | |||||
| Net unrealized loss on available-for-sale-securities | |||||
| Comprehensive loss | |||||
| Basic (in Dollars per share) | |||||
| Diluted (in Dollars per share) | |||||
| Shares used in computing net loss per share | |||||
| Basic (in Shares) | |||||
| Diluted (in Shares) | |||||
Loading...